跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOM-ALENDRONATE-FC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DOM-ALENDRONATE-FC
Authorized
STANDARD
DOM-ALENDRONATE-FC
dominion pharmacal
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d8ac805c091e8a37
Company
dominion pharmacal
Type
Standard
Approval Details
Approval Id
d8ac805c091e8a37
Drug Approval Canada Name
DOM-ALENDRONATE-FC
Product Name
DOM-ALENDRONATE-FC
Status
Cancelled Post Market
Status Date
2025-05-09
Original Market Date
2017-02-14
Din
02308398
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:24.00
Atc Original
M05BA04 ALENDRONIC ACID
Atc Name
m 05 ba 04
Aig Number
0150323002
Company Name
dominion pharmacal
Company Address
SUITE 100, 6111, Avenue Royalmount, Montreal, Quebec, Canada, H4P 2T4
Active Ingredients
ALENDRONIC ACID (ALENDRONATE SODIUM)
70 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d8ac805c091e8a37
Type
Standard
Back to Health Canada Approvals